Plain-English translation of NCT07272343 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial tests whether , a medication given by weekly injection, works better than following a calorie-restricted diet for people newly diagnosed with type 2 diabetes. The study will track how well each approach controls blood sugar, supports weight loss, and reduces inflammation in the liver and body. Researchers want to understand how this medication works at the cellular level to help guide future treatment decisions.
Many people with type 2 diabetes struggle to control their blood sugar and lose weight with diet alone. This trial aims to determine whether the medication might be a better option for newly diagnosed patients and to understand the biological reasons why it works.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either the injection group or the diet group. The injection group will receive a weekly shot that gradually increases in dose over 12 weeks. The diet group will follow a calorie-restricted eating plan tailored for your gender. Both groups will have their blood sugar, weight, liver fat, and inflammatory markers measured throughout the 12-week period to see which approach works best.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China